Clinical Trials Browser

Phase 3 × Has results × Cognitive Dysfunction × Clear all

NCT02360215 2025-04-23

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Phase 3 Completed

518 enrolled 40 charts

Brain Neoplasms, Cognitive Dysfunction

NCT02822573 2023-09-13

Remember

Phase 3 Completed

276 enrolled 33 charts

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction